Dr. Schneider is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1520 San Pablo St
Ste 1652
Los Angeles, CA 90033Phone+1 323-442-6000Fax+1 323-442-6001
Education & Training
- University of Southern California School of MedicineMS, Applied Biometry and Epidemiology, 1995
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Psychiatry, 1978 - 1983
- Drexel University College of MedicineClass of 1978
Certifications & Licensure
- CA State Medical License 1979 - 2025
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Geriatric Psychiatry
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- CATIE-Alzheimer's Disease Trial Start of enrollment: 2001 Mar 01
- Citalopram for Agitation in Alzheimer's Disease Start of enrollment: 2009 Jul 01
- Phytoserms for Menopause Symptoms and Age-Associated Memory Decline Start of enrollment: 2012 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 136 citationsSex, race, and smoking impact olanzapine exposure.Kristin L. Bigos, Bruce G. Pollock, Kim C. Coley, Del D. Miller, Stephen R. Marder
Journal of Clinical Pharmacology. 2008-02-01 - 194 citationsA novel Alzheimer disease locus located near the gene encoding tau proteinGyungah Jun, Carla A. Ibrahim-Verbaas, Maria Vronskaya, J-C Lambert, Jaeyoon Chung
Molecular Psychiatry. 2016-01-01 - 132 citationsTransethnic genome-wide scan identifies novel Alzheimer's disease lociGyungah Jun, Jaeyoon Chung, Jesse Mez, Robert Barber, Gary W. Beecham
Alzheimer's & Dementia. 2017-07-01
Press Mentions
- Alzheimer's Data WithdrawnNovember 11th, 2024
- If Alzheimer's Drug Ads Had More Data, Here's What Might HappenAugust 30th, 2024
- Challenges of Anti-Amyloid Therapies in Alzheimer’s Disease: Neurologists’ PerspectivesJuly 30th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: